* Difference in
immunoreactivity between endometrial hyperplasia with atypia and endometrioid carcinoma was not statistically significant.
Natriuretic peptide
immunoreactivity in nerve structures and Purkinje fibres of human, pig and sheep hearts.
Very weak
immunoreactivity of [beta]-catenin in the dental epithelium, as well as in surrounding mesenchyme.
(B) Photomicrograph of thymic lymphoma showing diffuse positive-staining reaction for cytoplasmic
immunoreactivity (arrows) (CD3, x400).
The authors observed a marked increase in the nuclear localization of p65 and in the I[kappa]B[alpha]
immunoreactivity in tissues obtained at term compared with tissues delivered preterm, suggesting a role for p65 in the regulation of parturition-related gene transcription in the decidua (59).
Whereas some studies have shown that p63 expression may occur in malignant serous carcinomas of the ovary, (30) other studies have suggested that p63
immunoreactivity may actually decrease with malignant progression in serous lesions.
examined ALP
immunoreactivity of 61 cytopathology samples from canine, consisting of 33 OSAs, 4 chondrosarcomas, 4 synovial sarcomas, 2 fibrosarcoma, 9 soft tissue sarcomas, 2 plasma cell tumours, 2 lymphomas, 2 amelanotic melanomas, 2 mast cell tumours, and 1 multilobular tumour (MLT) of bone, which showed sensitivity and specificity of 100% and 89% [13].
Yong et al., "Novel karyotypes and cyclin D1
Immunoreactivity in clear cell sarcoma of the kidney," Pediatric and Developmental Pathology, vol.
Contrary to OX42
immunoreactivity, the Western blot analysis showed that the increase in GFAP
immunoreactivity was belated and with statistical significance since 5 h following LPS injection with respect to the basal levels of untreated control rats (Figures 4(a) and 4(b)).
The
immunoreactivity of the GH cells in brackish waters was lower than that of FW as reflected by a significant decrease in their area, size, and immunostaining (Figures 3a-3h, 4A, and 4B).
In contrast to the study of Immervoll et al., our data shows the lower
immunoreactivity of CD44 in advanced PDAC (T3, N1) in comparison to locally advanced disease (T1, T2, and N0).
Caption: Figure 6: Integrated
immunoreactivity analysis of p38 mitogen-activated protein kinase (p38MAPK) in the ventrolateral periaqueductal gray (vlPAG).
